Notice2024-03784
Proposed Updates for Developing, Implementing, and Evaluating Infection Control Programs for Viral Hemorrhagic Fevers, Andes Virus, and Nipah Virus: Appendix A
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 26, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on Draft Proposed Updates for Viral hemorrhagic fevers, Andes virus, and Nipah virus: Appendix A ("Draft Updates: Appendix A"). The updated recommendations in the Draft Updates: Appendix A are intended for use by frontline healthcare personnel, as well as infection control personnel and other persons responsible for developing, implementing, and evaluating infection control programs for healthcare settings across the continuum of care.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 38 (Monday, February 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 38 (Monday, February 26, 2024)]
[Notices]
[Pages 14074-14075]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-03784]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0015]
Proposed Updates for Developing, Implementing, and Evaluating
Infection Control Programs for Viral Hemorrhagic Fevers, Andes Virus,
and Nipah Virus: Appendix A
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) in the
Department of Health and Human Services (HHS) announces the opening of
a docket to obtain comment on Draft Proposed Updates for Viral
hemorrhagic fevers, Andes virus, and Nipah virus: Appendix A (``Draft
Updates: Appendix A''). The updated recommendations in the Draft
Updates: Appendix A are intended for use by frontline healthcare
personnel, as well as infection control personnel and other persons
responsible for developing, implementing, and evaluating infection
control programs for healthcare settings across the continuum of care.
DATES: Written comments must be received on or before April 26, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0015 by either of the methods listed below. Do not submit comments by
email. CDC does not accept comments by email.
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Healthcare Infection Control Practices Advisory
Committee (HICPAC) Secretariat, Division of Healthcare Quality
Promotion, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329, Attn: Docket Number
CDC-2024-0015.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to <a href="http://regulations.gov">http://regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
FOR FURTHER INFORMATION CONTACT: Laura Wells, Division of Healthcare
Quality Promotion, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H16-2, Atlanta, Georgia 30329; Telephone:
(404) 639-4000.
SUPPLEMENTARY INFORMATION:
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data related to Draft
Updates: Appendix A.
Please note that comments received, including attachments and other
supporting materials, are part of the public record and are subject to
public disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Therefore, do not include any information in your
comment or supporting materials that you consider confidential or
inappropriate for public disclosure. If you include your name, contact
information, or other information that identifies you in the body of
your comments, that information will be on public display. CDC will
review all submissions and may choose to redact, or withhold,
submissions containing private or proprietary information such as
Social Security numbers, medical information, inappropriate language,
or duplicate/near duplicate examples of a mass-mail campaign. Do not
submit comments by email. CDC does not accept comment by email.
Background
The Draft Updates: Appendix A, located in the ``Supporting and
Related Material'' tab of the docket, updates the recommendations in
Appendix A of the Guideline for Isolation Precautions: Preventing
Transmission of Infectious Agents in Healthcare Settings (2007) on the
type and duration of isolation precautions for Viral hemorrhagic
fevers, Andes virus, and Nipah virus. The Draft Updates: Appendix A
provides recommendations to prevent transmission, focusing primarily on
types and durations of precautions available to frontline healthcare
personnel. The recommendations are being updated to include additional
viruses with potential for importation to the United States. The Draft
Updates: Appendix A is intended for use by frontline healthcare
personnel, as well as infection control personnel and other persons
responsible for developing, implementing, and evaluating infection
control programs for healthcare settings across the continuum of care.
Once the Draft Updates: Appendix A is finalized, the corresponding
content in Appendix A of the Guideline for Isolation Precautions:
Preventing Transmission of Infectious Agents in Healthcare Settings
(2007) will be updated on the CDC
[[Page 14075]]
Infection Control website (<a href="https://www.cdc.gov/infectioncontrol/guidelines/isolation/appendix/index.html">https://www.cdc.gov/infectioncontrol/guidelines/isolation/appendix/index.html</a>).
The updated recommendations in Draft Updates: Appendix A are
informed by review and consideration of available literature on
transmission principles and infection prevention and control practices
for each virus. Draft recommendations were presented to the Healthcare
Infection Control Practices Advisory Committee (HICPAC), whose feedback
was incorporated into the finalized draft recommendations. HICPAC is a
Federal advisory committee appointed to provide advice and guidance to
HHS and CDC regarding the practice of infection control and strategies
for surveillance, prevention, and control of healthcare-associated
infections, antimicrobial resistance, and related topics in United
States healthcare settings. HICPAC includes, but is not limited to,
representatives with expertise in public health, infectious diseases,
and infection prevention and control. HICPAC also includes ex officio
members who represent regulatory and other Federal agencies and liaison
representatives from professional societies.
CDC is seeking comments on the Draft Updates: Appendix A. Please
provide references to new evidence and justification to support any
suggested revisions or additions. This Draft Updates: Appendix A is not
a Federal rule or regulation.
Noah Aleshire,
Chief Regulatory Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-03784 Filed 2-23-24; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on February 26, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.